VTE is pervasive

The burden of illness is significant

Too often, VTE is a silent killer1,2

For 1 in 4 patients, a fatal PE is the first symptom of VTE3

VTE Webnar

Register for the webinar*
Venous Thromboembolism: Pervasive, Persistent, Preventable

First in a series of live peer-to-peer webinars about the unmet need for VTE prophylaxis in acutely ill medical patients after hospital discharge.

*For US health care professionals only.

See the full scope of this deadly
yet preventable problem1,4

A global threat that impacts millions

In G7 countries*, VTE is a major public health problem5-8

>24 million hospitalized acutely ill medical patients

~22.5 million at risk of VTE events

>1 million VTE events

>150,000 VTE DEATHS

*G7 countries: Canada, France, Germany, Italy, Japan, the United Kingdom, and the United States.

1 in 4 people worldwide die of VTE-related conditions

people worldwide die of VTE-related conditions9,10

World Thrombosis Day

In the US, VTE is deadlier than colon cancer, diabetes, flu, and pneumonia2,11,12

VTE causes ~100,000 confirmed annual deaths in the United States alone2

ATTRIBUTABLE ANNUAL US DEATHS PER CONDITION

COLON CANCER
52%52K
FLU/ PNEMONIA
55%55K
DIABETES
76%76K
TOTAL VTE (DVT/PE)
100%100K

US=United States; DVT=deep vein thrombosis; PE=pulmonary embolism.

VTE Newsletter Signup

Register for updates*

Concerned about your acutely ill medical patients and VTE?
Sign up to receive updates and access to new resources as they become available.

*For US health care professionals only.

References
  1. Futterman LG, Lemberg L. A silent killer—often preventable. Am J Crit Care. 2004;13(5):431-436.
  2. Office of the Surgeon General and National Heart, Lung, and Blood Institute (US). The Surgeon General's Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism. Rockville, MD: Office of the Surgeon General (US); 2008.
  3. Beckman MG, Hooper WC, Critchley SE, Ortel TL. Venous thromboembolism: a public health concern. Am J Prev Med. 2010;38(4S):S495-S501.
  4. Korjian S, Daaboul Y, Halaby R, et al. Extended-duration thromboprophylaxis among acute medically ill patients: an unmet need. J Cardiovasc Pharmacol Ther. 2016;21(3):227-232.
  5. Roger VL, Go AS, Lloyd-Jones DM, et al; the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2011 update. Circulation. 2011;123(4);e18-e209.
  6. Ng TMH, Tsai F, Khatri N, Barakat MN, Elkayam U. Venous thromboembolism in hospitalized patients with heart failure: incidence, prognosis, and prevention. Circ Heart Fail. 2010;3(1):165-173.
  7. Kelly J, Rudd A, Lewis R, Hunt BJ. Venous thromboembolism after acute stroke. Stroke. 2001;32(1):262-267.
  8. Tapson VF. The role of smoking in coagulation and thromboembolism in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005;2(1):71-77.
  9. International Society on Thrombosis and Haemostasis, Inc. Know Thrombosis. World Thrombosis Day website. http://www.worldthrombosisday.org/issue/thrombosis. Accessed April 4, 2017.
  10. ISTH Steering Committee for World Thrombosis Day. Thrombosis: a major contributor to global disease burden. J Thromb Haemost. 2014;12(10):1580-1590.
  11. Division of Cancer Prevention and Control, Centers for Disease Control and Prevention. Colorectal cancer statistics. Centers for Disease Controal Prevention website. http://www.cdc.gov/cancer/colorectal statistics. Updated June 20, 2016. Accessed March 7, 2017.
  12. National Center for Health Statistics. Centers for Disease Control and Prevention. CDC Health, United States, 2015. Hyattsville, Maryland: Department of Health and Human Services; 2016.

Worried about VTE risk?  Learn About A Treatment Option

Okay Okay Okay Okay Okay  Cancel